Verified peer comparison
Sagimet Biosciences Inc. - Series A Common Stock vs Marchex, Inc. - Class B Common Stock Financial Comparison
Sagimet Biosciences Inc. - Series A Common Stock versus Marchex, Inc. - Class B…
Direct answer
Sagimet Biosciences Inc. - Series A Common Stock and Marchex, Inc. - Class B Common Stock are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Sagimet Biosciences Inc. - Series A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Sagimet Biosciences Inc. - Series A Common Stock Revenue
- 0 USD
- Marchex, Inc. - Class B Common Stock Revenue
- 45,420,000 USD
- Sagimet Biosciences Inc. - Series A Common Stock Operating income
- -56,889,000 USD
- Marchex, Inc. - Class B Common Stock Operating income
- -4,374,000 USD